Stock TLIS TALIS BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
9.07 USD -0.77% Intraday chart for Talis Biomedical Corporation +0.67% +21.74%
Apr. 02 North American Morning Briefing : Stocks Seen -2- DJ
Mar. 28 Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Talis: Q3 Earnings Snapshot
AQ
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
AQ
Talis: Q2 Earnings Snapshot
AQ
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
AQ
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
AQ
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
AQ
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
AQ
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
AQ
Talis Biomedical Announces 1-for-15 Reverse Stock Split
GL
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
BU
TALIS BIOMEDICAL CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
GL
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
AQ
Talis: Q1 Earnings Snapshot
AQ
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
GL
TALIS BIOMEDICAL CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
GL
TALIS BIOMEDICAL CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
TALIS BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TLIS Stock
  4. News Talis Biomedical Corporation
  5. Press Releases